Severe COVID-19 during pregnancy in Sweden, Norway, and Denmark. 2023

Anne K Örtqvist, and Maria C Magnus, and Anna J M Aabakke, and Stine Kjaer Urhoj, and Anne Vinkel Hansen, and Anne-Marie Nybo Andersen, and Lone Krebs, and Karin Pettersson, and Siri E Håberg, and Olof Stephansson
Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.

Pregnancy is a risk factor for severe coronavirus disease 2019 (COVID-19) and adverse pregnancy outcomes. We aimed to explore maternal characteristics, pregnancy outcomes, vaccination status, and virus variants among pregnant women admitted to intensive care units (ICU) with severe COVID-19. We identified pregnant women admitted to ICU in Sweden (n = 96), Norway (n = 31), and Denmark (n = 16) because of severe COVID-19, from national registers and clinical databases between March 2020 and February 2022 (Denmark), August 2022 (Sweden), or December 2022 (Norway). Their background characteristics, pregnancy outcome, and vaccination status were compared with all birthing women and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) test-positive pregnant women during the same time period. We calculated the number admitted to ICU per 10 000 birthing and per 1000 SARS-CoV-2 test-positive women during the Index, Alpha, Delta, and Omicron periods. Women admitted to ICU had a higher mean body mass index, were more often of non-Scandinavian origin, had on average lower education and income levels, had a higher proportion of chronic and pregnancy-related conditions, delivered preterm, had neonates with low Apgar scores, and had more infants admitted to neonatal care, compared with all birthing and test-positive pregnant women. Of those admitted to ICU, only 7% had been vaccinated before admission. Overall, the highest proportion of women admitted to ICU per birthing was during the Delta period (4.1 per 10 000 birthing women). In Norway, the highest proportion admitted to ICU per test-positive pregnant women was during the Delta period (17.8 per 1000 test-positive), whereas the highest proportion of admitted per test-positive in Sweden and Denmark was seen during the Index period (15.4 and 8.9 per 1000 test-positive, respectively). Admission to ICU because of COVID-19 in pregnancy was a rare event in the Scandinavian countries, but women who were unvaccinated, of non-Scandinavian origin, and with lower socio-economic status were at higher risk of admission to ICU. In addition, women admitted to ICU for COVID-19 had higher risk of adverse pregnancy outcomes.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D009664 Norway A country located in northern Europe, bordering the North Sea and the Atlantic Ocean, west of Sweden. The capital is Oslo. Kingdom of Norway
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011251 Pregnancy Complications, Infectious The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION. Complications, Infectious Pregnancy,Infectious Pregnancy Complications,Maternal Sepsis,Pregnancy, Infectious Complications,Sepsis during Pregnancy,Sepsis in Pregnancy,Infectious Pregnancy Complication,Pregnancy Complication, Infectious,Sepsis in Pregnancies,Sepsis, Maternal
D011256 Pregnancy Outcome Results of conception and ensuing pregnancy, including LIVE BIRTH; STILLBIRTH; or SPONTANEOUS ABORTION. The outcome may follow natural or artificial insemination or any of the various ASSISTED REPRODUCTIVE TECHNIQUES, such as EMBRYO TRANSFER or FERTILIZATION IN VITRO. Outcome, Pregnancy,Outcomes, Pregnancy,Pregnancy Outcomes
D003718 Denmark A country in northern Europe, bordering the Baltic Sea and the North Sea. The capital is Copenhagen. Faeroe Islands,Faroe Islands
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19

Related Publications

Anne K Örtqvist, and Maria C Magnus, and Anna J M Aabakke, and Stine Kjaer Urhoj, and Anne Vinkel Hansen, and Anne-Marie Nybo Andersen, and Lone Krebs, and Karin Pettersson, and Siri E Håberg, and Olof Stephansson
May 2024, European journal of public health,
Anne K Örtqvist, and Maria C Magnus, and Anna J M Aabakke, and Stine Kjaer Urhoj, and Anne Vinkel Hansen, and Anne-Marie Nybo Andersen, and Lone Krebs, and Karin Pettersson, and Siri E Håberg, and Olof Stephansson
February 2021, Scandinavian journal of public health,
Anne K Örtqvist, and Maria C Magnus, and Anna J M Aabakke, and Stine Kjaer Urhoj, and Anne Vinkel Hansen, and Anne-Marie Nybo Andersen, and Lone Krebs, and Karin Pettersson, and Siri E Håberg, and Olof Stephansson
February 2022, Scandinavian journal of public health,
Anne K Örtqvist, and Maria C Magnus, and Anna J M Aabakke, and Stine Kjaer Urhoj, and Anne Vinkel Hansen, and Anne-Marie Nybo Andersen, and Lone Krebs, and Karin Pettersson, and Siri E Håberg, and Olof Stephansson
March 2024, Journal of infection and public health,
Anne K Örtqvist, and Maria C Magnus, and Anna J M Aabakke, and Stine Kjaer Urhoj, and Anne Vinkel Hansen, and Anne-Marie Nybo Andersen, and Lone Krebs, and Karin Pettersson, and Siri E Håberg, and Olof Stephansson
November 1955, Geriatrics,
Anne K Örtqvist, and Maria C Magnus, and Anna J M Aabakke, and Stine Kjaer Urhoj, and Anne Vinkel Hansen, and Anne-Marie Nybo Andersen, and Lone Krebs, and Karin Pettersson, and Siri E Håberg, and Olof Stephansson
January 1947, Revista chilena de pediatria,
Anne K Örtqvist, and Maria C Magnus, and Anna J M Aabakke, and Stine Kjaer Urhoj, and Anne Vinkel Hansen, and Anne-Marie Nybo Andersen, and Lone Krebs, and Karin Pettersson, and Siri E Håberg, and Olof Stephansson
October 2020, The journal of headache and pain,
Anne K Örtqvist, and Maria C Magnus, and Anna J M Aabakke, and Stine Kjaer Urhoj, and Anne Vinkel Hansen, and Anne-Marie Nybo Andersen, and Lone Krebs, and Karin Pettersson, and Siri E Håberg, and Olof Stephansson
June 1957, American journal of pharmacy and the sciences supporting public health,
Anne K Örtqvist, and Maria C Magnus, and Anna J M Aabakke, and Stine Kjaer Urhoj, and Anne Vinkel Hansen, and Anne-Marie Nybo Andersen, and Lone Krebs, and Karin Pettersson, and Siri E Håberg, and Olof Stephansson
January 1974, Nordisk veterinaermedicin,
Anne K Örtqvist, and Maria C Magnus, and Anna J M Aabakke, and Stine Kjaer Urhoj, and Anne Vinkel Hansen, and Anne-Marie Nybo Andersen, and Lone Krebs, and Karin Pettersson, and Siri E Håberg, and Olof Stephansson
June 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin,
Copied contents to your clipboard!